The PreCheck program was launched to boost domestic pharmaceutical manufacturing in the US. It focuses on increasing production capacity and supply chain resilience. Regulatory developments also include blood-based tests for Alzheimer's detection.

Program Objectives

PreCheck aims to reduce reliance on foreign suppliers by incentivizing local production.

Additional Highlights

Topics include advancements in biomarker tests, as outlined in PCORI's innovation brief shared on X.